Search Results
Ali Mortazavi, CEO of Silence Therapeutics (SLN) at SHARES Investor Evenings
Silence Therapeutics - Investor Day Presentation by ALI MORTAZAVI
Silence Therapeutics CEO on £40mln fundraise
e-Therapeutics (ETX) - Ali Mortazavi, Chairman & CEO
e-Therapeutics (ETX) - Ali Mortazavi, Executive Chairman
Breaking News | Silence Therapeutics Boss Ali Mortazavi Leaves After Six Years
e-therapeutics Chairman Mortazavi takes over CEO duties, 'solving a big unmet need in the industry'
Silence Therapeutics - Investor Day Presentation by MIKE KHAN
e-Therapeutics PLC's Ali Mortazavi welcomes new fibrosis collaboration with Galapagos
Silence Therapeutics (SLN) - Dr. Rob Quinn, Interim CFO
Ali Mortazavi, UCI - RNA Symposium
New GalNAc delivery technology 'a game-changer' says Silence Therapeutics chief